Anhui Zhifei Longcom: Omicron-Delta Recombinant Novel Coronavirus Protein Vaccine (CHO cells)

Vaccine Type: Protein Subunit

Vaccine Trial & Approval Tracker

This vaccine has reached Phase 3 trials.

About Trial Phases

Phase 1: 0 Trials

There are no trials for this phase.

Phase 2: 0 Trials

There are no trials for this phase.

Phase 3: 1 Trial

Approvals

This vaccine is not yet approved.

Registered Trials